Evidence map›Paper›PMID 24807488›Full record

ReviewInternational journal of urology : official journal of the Japanese Urological Association2014

Bladder afferent hyperexcitability in bladder pain syndrome/interstitial cystitis.

Naoki Yoshimura, Tomohiko Oguchi, Hitoshi Yokoyama, Yasuhito Funahashi, Satoru Yoshikawa, Yoshio Sugino, Naoki Kawamorita, Mahendra P Kashyap, Michael B Chancellor, Pradeep Tyagi and 1 more

Abstract readReview
In one paragraph

Review in International journal of urology : official journal of the Japanese Urological Association, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 1 synthesis or guideline pooled it, 107 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review of BCG immunotherapy for bladder cancer.Clinical microbiology reviews · 2025
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Naoki YoshimuraDepartment of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Tomohiko Oguchi
Hitoshi Yokoyama
Yasuhito Funahashi
Satoru Yoshikawa
Yoshio Sugino
Naoki Kawamorita
Mahendra P Kashyap
Michael B Chancellor
Pradeep Tyagi
Teruyuki Ogawa
University of Pittsburgh · USBeaumont Hospital, Royal Oak · US

Funding

PRE-CLINICAL VECTOR PRODUCTIONP01DK044935 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GOINS, WILLIAM F. · 1993 to 2010
$11.8M
Pharmacology of Intravesical Antisense Based Therapy for Over Active BladderR01DK088836 · NIDDK · WILLIAM BEAUMONT HOSPITAL RESEARCH INST · PI CHANCELLOR, MICHAEL B, TYAGI, PRADEEP · 2011 to 2014
$1.3M
NIDDK NIH HHS DK088836NIDDK NIH HHS P01 DK044935NIDDK NIH HHS R01 DK088836
6 · The paper itself

Abstract

Bladder pain syndrome/interstitial cystitis is a disease with lower urinary tract symptoms, such as bladder pain and urinary frequency, which results in seriously impaired quality of life of patients. The extreme pain and urinary frequency are often difficult to treat. Although the etiology of bladder pain syndrome/interstitial cystitis is still not known, there is increasing evidence showing that afferent hyperexcitability as a result of neurogenic bladder inflammation and urothelial dysfunction is important to the pathophysiological basis of symptom development. Further investigation of the pathophysiology will lead to the effective treatment of patients with bladder pain syndrome/interstitial cystitis.

Indexed as

Afferent PathwaysCystitis, InterstitialInflammationNeuronal PlasticityAnti-Inflammatory Agents, Non-SteroidalCytokinesHumansLower Urinary Tract SymptomsNerve Growth FactorQuality of LifeSensory System AgentsTherapies, InvestigationalUrethraUrinary BladderAnti-Inflammatory Agents, Non-SteroidalCytokinesNerve Growth FactorSensory System Agentsafferent pathwaybladder pain syndromecytokineinterstitial cystitisnerve growth factor

Identifiers

PMID24807488
PMCPMC4089034
OpenAlexW1548879124

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.